Table 1 lists the characteristics of the 82 kidney transplant recipients (FSGS, focal segmental glomerulosclerosis; TSAT, transferrin saturation; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker). This evidence concerns the gene ACE and urogenital neoplasm.